---
title: Assessing carnosinase 1 activity for diagnosing congenital disorders of glycosylation
date: '2024-09-03'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39226631/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240904183716&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Diagnosing Congenital Disorders of Glycosylation (CDG) is challenging
  due to clinical heterogeneity and the limited sensitivity of the classic serum transferrin
  isoelectric focusing (IEF) or capillary zone electrophoresis test. This study investigates
  the potential of using the glycoprotein carnosinase 1 (CN1) activity as a diagnostic
  marker for CDG patients. CN1 activity was measured photometrically in serum from
  81 genetically confirmed CDG patients and healthy individuals. While the ...
disable_comments: true
---
Diagnosing Congenital Disorders of Glycosylation (CDG) is challenging due to clinical heterogeneity and the limited sensitivity of the classic serum transferrin isoelectric focusing (IEF) or capillary zone electrophoresis test. This study investigates the potential of using the glycoprotein carnosinase 1 (CN1) activity as a diagnostic marker for CDG patients. CN1 activity was measured photometrically in serum from 81 genetically confirmed CDG patients and healthy individuals. While the ...